loader from loading.io

241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?

Let's Talk Micro

Release Date: 07/02/2026

241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance? show art 241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?

Let's Talk Micro

Recorded live at ASM Microbe 2026 in Washington, DC, this special episode marks the first live recording of Let's Talk Micro. Joining me are co-host Dr. Andrea Prinzi and guest Dr. Nathan Ledeboer for a discussion on the evolving role of whole genome sequencing (WGS) in clinical microbiology and antimicrobial resistance. Can whole genome sequencing predict antimicrobial susceptibility? What are its current limitations? How close are we to incorporating WGS into routine clinical microbiology laboratories? Throughout the conversation, we explore the opportunities and challenges of implementing...

info_outline
240: CLSI M100 2026: Actualizaciones show art 240: CLSI M100 2026: Actualizaciones

Let's Talk Micro

En este episodio en español de Let's Talk Micro, Luis conversa nuevamente con el Dr. Germán Esparza sobre los cambios más relevantes incluidos en la edición 2026 del documento CLSI M100. Durante la conversación, revisan nuevas opciones terapéuticas como aztreonam-avibactam, actualizaciones en los puntos de corte para Acinetobacter y Neisseria gonorrhoeae, cambios en aminoglucósidos, consideraciones de control de calidad y los desafíos asociados con las pruebas de susceptibilidad para el complejo Burkholderia cepacia. Además, discuten cómo los laboratorios pueden evaluar e implementar...

info_outline
239: Inside ASM Microbe 2026 show art 239: Inside ASM Microbe 2026

Let's Talk Micro

ASM Microbe is the largest microbiology meeting in the United States, bringing together thousands of scientists, laboratorians, clinicians, and industry partners to discuss the latest advances in microbiology. In this episode, Luis shares highlights from ASM Microbe 2026, including sessions on diagnostic challenges, antimicrobial resistance, rapid susceptibility testing, emerging therapeutics, laboratory automation, phage therapy, and whole-genome sequencing. Topics include a Brucella case that reinforces the importance of Gram stain interpretation, updates on resistance mechanisms in...

info_outline
238: From the Bench to CPEP: An MLS Journey show art 238: From the Bench to CPEP: An MLS Journey

Let's Talk Micro

What does it take to go from working at the bench to becoming a future clinical microbiology laboratory director? In this episode, Luis is joined by Dr. Mackenzie Collins, a CPEP fellow at UCLA, to discuss her journey from Medical Laboratory Scientist (MLS) to PhD scientist and CPEP fellow. Mackenzie shares how she discovered laboratory medicine, her experience working as an MLS in molecular microbiology, and the mentors and opportunities that helped shape her career path. The conversation explores the CPEP fellowship, the role of laboratory directors, and how MLS professionals can strengthen...

info_outline
237: Micro Minutes: A Case of Mistaken Identity show art 237: Micro Minutes: A Case of Mistaken Identity

Let's Talk Micro

Have you ever received an identification result that just didn't make sense? In this episode, Luis shares three cases of mistaken identity from the microbiology laboratory: a Gram-positive rod identified as Kocuria, another reported as Sphingomonas, and a yeast that somehow became Brucella. While automated identification systems are powerful tools, they can only work with the information we provide. These examples highlight an important lesson for every microbiologist: always correlate the identification with the Gram stain, colony morphology, and other bench observations. When the result...

info_outline
236:  Let's Talk Andes Virus show art 236: Let's Talk Andes Virus

Let's Talk Micro

In Part 2 of this hantavirus series, Luis continues the conversation with Dr. Ryan Relich and Dr. Stephanie Seifert by focusing on the recent Andes virus cruise ship outbreak and what makes this hantavirus different from others. The discussion explores the outbreak investigation, the evidence for person-to-person transmission, and why the Andes virus has received so much attention from the public health community. Ryan and Stephanie also discuss diagnostic testing, including PCR and serology, the role of public health laboratories, current treatment options, prevention strategies, and how...

info_outline
235: Let’s Talk Hantavirus show art 235: Let’s Talk Hantavirus

Let's Talk Micro

Hantaviruses have recently been in the headlines, but what exactly are they and how do they spread? In Part 1 of this hantavirus series, Luis is joined by Dr. Ryan Relich and Dr. Stephanie Seifert for a deep dive into the world of hantaviruses. The conversation explores the basics of hantaviruses, including their ecology, rodent reservoirs, transmission, and the diseases they cause in humans. The guests also discuss Old World vs New World hantaviruses, hantavirus pulmonary syndrome (HPS), environmental risk factors, climate influences, and why these infections may be underdiagnosed. From deer...

info_outline
234: High School, the Laboratory, and Workforce Development show art 234: High School, the Laboratory, and Workforce Development

Let's Talk Micro

Workforce shortages continue to impact clinical laboratories across the country, especially in rural healthcare settings. In this episode of Let’s Talk Micro, Luis is joined by Kenzi Haigler to discuss an innovative high school laboratory program designed to introduce students to laboratory medicine early and help strengthen the future workforce pipeline. Kenzi shares her journey into the laboratory profession, her experiences working in rural healthcare, and the unique challenges small hospitals face when it comes to staffing, training, and retaining laboratory professionals. She also...

info_outline
233: The Background Singers of Gram-Negative Cocci show art 233: The Background Singers of Gram-Negative Cocci

Let's Talk Micro

In this episode of Let’s Talk Micro, we close out our gram-negative cocci series by talking about the “background singers” of the group—the organisms that quietly show up on respiratory cultures and oral flora plates every day. We explore the world of non-pathogenic Neisseria species, along with rod-shaped and coccobacillary Neisseria and Moraxella that break the classic gram-negative diplococci rule. From commensals and opportunistic pathogens to their role in respiratory cultures and bench identification, this episode focuses on how to think through these isolates in the clinical...

info_outline
232: What’s New at ASM Microbe 2026? show art 232: What’s New at ASM Microbe 2026?

Let's Talk Micro

This week, Let’s Talk Micro is pausing the Gram-negative cocci series to talk about one of the biggest microbiology meetings of the year: ASM Microbe 2026. Luis is joined by Dr. Bobbi Pritt and Dr. Robert Tibbetts to discuss what attendees can expect from this year’s meeting in Washington, DC. The conversation covers the new meeting structure, important trends in clinical microbiology, sessions and workshops geared toward medical laboratory scientists, networking opportunities, and tips for getting the most out of the conference experience. They also discuss hot topics such as AI-driven...

info_outline
 
More Episodes

Recorded live at ASM Microbe 2026 in Washington, DC, this special episode marks the first live recording of Let's Talk Micro. Joining me are co-host Dr. Andrea Prinzi and guest Dr. Nathan Ledeboer for a discussion on the evolving role of whole genome sequencing (WGS) in clinical microbiology and antimicrobial resistance.

Can whole genome sequencing predict antimicrobial susceptibility? What are its current limitations? How close are we to incorporating WGS into routine clinical microbiology laboratories? Throughout the conversation, we explore the opportunities and challenges of implementing sequencing technologies, including bioinformatics, workflow, reimbursement, and the need for continued collaboration between microbiologists, infectious diseases specialists, pharmacists, and antimicrobial stewardship teams.

We also discuss how WGS may transform outbreak investigations, epidemiologic surveillance, and the future role of the clinical microbiologist as advanced diagnostics become increasingly integrated into patient care.

Whether you're a bench microbiologist, laboratory leader, infectious diseases professional, or student, this episode offers an exciting look at where clinical microbiology is headed and what whole genome sequencing can realistically tell us about antimicrobial resistance.

Stay connected with Let’s Talk Micro:

Support the podcast: